je.st
news
Tag: therapy
ViewRay to Showcase World's Only MRI-Guided Radiation Therapy System In Clinical Use at ...
2014-09-12 06:00:00| Industrial Newsroom - All News for Today
Doctors from Leading Cancer Center Will Discuss Firsthand Experience with MRIdian's Adaptive and Soft-Tissue Tracking Capabilities<br /> <br /> CLEVELAND - ViewRay™, a privately held medical device company, announced today that it will showcase its MRIdian™ (me-rid-i-an) system, the world's first and only MRI-guided radiation therapy system, at the 56(th) Annual Meeting of the American Society for Radiation Oncology (ASTRO) being held September 14-17, 2014 in San Francisco. ...This story is related to the following:Vision SystemsSearch for suppliers of: Medical Imaging Systems
Tags: use
system
clinical
therapy
Varian Medical Systems Completes Commissioning of Five Proton Therapy Treatment Rooms Plus ...
2014-09-12 06:00:00| Industrial Newsroom - All News for Today
ProBeam version 2.5 successfully installed to enhance workflow at the San Diego site; technology is on display at the ASTRO meeting in San Francisco<br /> <br /> SAN FRANCISCO - ASTRO Booth #618 - Varian Medical Systems (NYSE: VAR) today announced that the company completed commissioning of five treatment rooms at the Scripps Proton Therapy Center earlier this year, and has upgraded the ProBeam® system software. The upgrade to ProBeam 2.5 will enhance workflow at the site, enable the use of ...This story is related to the following:Vision SystemsMedical & Health Care Software | Radiotherapy Systems
Tags: plus
systems
medical
treatment
FTC sues AbbVie, Teva over testosterone replacement therapy deal
2014-09-09 11:55:23| Biotech - Topix.net
The Federal Trade Commission filed a complaint Monday against AbbVie and Teva Pharmaceutical Industries alleging the companies illegally blocked American consumers' access to lower-cost versions of the testosterone replacement therapy AndroGel. According to the FTC complaint, AbbVie of Chicago and its partner Besins Healthcare Inc. allegedly filed baseless patent infringement lawsuits against potential generic competitors to delay the introduction of lower-priced versions of AndroGel, which generates more than $1 billion a year in annual sales.
Tags: deal
therapy
replacement
sues
ViewRay's MRIdian Makes Adaptive Radiation Therapy a Clinical Reality
2014-09-09 06:00:00| Industrial Newsroom - All News for Today
World's First On-Table Adaptive Radiation Therapy Clinical Program Commenced at Siteman Cancer Center<br /> <br /> CLEVELAND, -- ViewRay(TM) Incorporated, a privately held medical device company, announced today that the world's first on-table adaptive radiation treatment program using the MRIdian(TM) (me-rid-i-an) system began at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis. The MRIdian system provides a patented combination ...This story is related to the following:Magnetic Resonance Imaging (MRI) Scanners
Tags: makes
reality
clinical
therapy
Merck Receives Accelerated Approval of KEYTRUDA (pembrolizumab), the First FDA-Approved Anti-PD-1 Therapy
2014-09-04 21:15:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA (pembrolizumab) at a dose of 2 mg/kg every three weeks for the treatment of patients with unresectable or metastatic melanoma and disease progression following ipilimumab and, if BRAF V600 mutation positive, a BRAF inhibitor. This indication is approved under accelerated approval based on tumor response rate and durability of response. Language: English Contact: MerckMedia:Ian McConnell, 908-423-3046orClaire Mulhearn, 908-423-7425orInvestor:Joseph Romanelli, 908-423-5185orJustin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: approval
therapy
receives
accelerated
Sites : [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] next »